In 2023, Coke consumption in the manufacture of medicines in China stood at an unspecified baseline. Forecast data from 2024 to 2028 shows a steady increase from 6.0 to 6.78 ten thousand metric tons, reflecting a consistent growth trend. Year-on-year variations indicate an average increase of approximately 3.1%. Over this five-year period, the compound annual growth rate (CAGR) is projected at 3.1%. This highlights a stable growth trajectory for coke usage in this sector.
Future trends to monitor include:
- Technological advancements in manufacturing processes that might affect coke usage.
- Policy changes related to environmental standards impacting coke consumption levels.
- Market demand shifts for medication types which could influence coke requirements in manufacturing.
